Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 3/2013

01-03-2013 | Original paper

Self-reported side effects of breast cancer treatment: a cross-sectional study of incidence, associations, and the influence of exercise

Authors: Sheridan A. Gho, Julie R. Steele, Sandra C. Jones, Bridget J. Munro

Published in: Cancer Causes & Control | Issue 3/2013

Login to get access

Abstract

Purpose

Side effects as a result of breast cancer treatment may have a lasting detrimental impact on quality of life. Exercise has been shown to be an effective intervention in post-treatment care. This study aimed to gain a better understanding of breast cancer treatment-related side effects through identifying potential patient characteristic associations, including current levels of exercise.

Methods

Four hundred and thirty-two breast cancer patients completed an online survey covering their treatment and demographic background, current exercise levels, and self-reported treatment side effects. Side effects were considered in a binary logistic regression against age, surgery, currently undergoing treatment, and exercise levels to ascertain significant relationships (p < 0.05) and associative values (Odds Ratio).

Results

Lumpectomy patients were less likely to report aching muscles (OR 0.61, 95 % CI 0.39–0.96), hot flushes (OR 0.60, 95 % CI 0.38–0.96), and weight gain (OR 0.59, 95 % CI 0.38–0.92) than mastectomy patients. Women currently undergoing treatment were more likely to report hot flushes (OR 3.77, 95 % CI 2.34–6.08), aching muscles (OR 1.62, 95 % CI 1.02–2.57), and weight gain (OR 1.89, 95 % CI 1.19–2.99) than women finished treatment. Sedentary women were more likely to experience shoulder limitations (OR 1.77, 95 % CI 1.14–2.77), muscular chest wall pain (OR 1.69, 95 % CI 1.07–2.65), weight gain (OR 2.29, 95 % CI 1.44–3.64), lymphedema (OR 1.68, 95 % CI 1.04–2.71), and breathlessness (OR 2.30 95 % CI 1.35–3.92) than their physically active counterparts.

Conclusions

Patient characteristics may inform interventions to improve care post-breast cancer treatment. Sufficient levels of exercise were consistently associated fewer side effects and should be encouraged.
Literature
1.
Janz NK, Mujahid M, Chung LK et al (2007) Symptom experience and quality of life of women following breast cancer treatment. J Women’s Health 16:1348–1361CrossRef
2.
Burstein HJ, Winer EP (2000) Primary care for survivors of breast cancer. New Engl J Med 343:1086–1094PubMedCrossRef
3.
Shapiro CL, Recht A (2001) Drug therapy—side effects of adjuvant treatment of breast cancer. New Engl J Med 344:1997–2008PubMedCrossRef
4.
Cella D, Fallowfield LJ (2008) Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Tr 107:167–180CrossRef
5.
Jim H, Andrykowski M, Munster P, Jacobsen P (2007) Physical symptoms/side effects during breast cancer treatment predict posttreatment distress. Ann Behavioral Med 34:200–208CrossRef
6.
Meeske K, Smith A, Alfano C et al (2007) Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Qual Life Res 16:947–960PubMedCrossRef
7.
Arndt V, Stegmaier C, Ziegler H, Brenner H (2006) A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer 107:2496–2503PubMedCrossRef
8.
Hayes SC, Rye S, Battistutta D, DiSipio T, Newman B (2010) Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Out 8:92–98CrossRef
9.
Nesvold I, Reinertsen K, Fosså S, Dahl A (2010) The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study. J Cancer Surviv 5(1):62–72
10.
Buijs C, de Vries EGE, Mourits MJE, Willemse PHB (2008) The influence of endocrine treatments for breast cancer on health-related quality of life. Cancer Treat Rev 34:640–655PubMedCrossRef
11.
Atkins L, Fallowfield L (2006) Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer 42:2271–2276PubMedCrossRef
12.
McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS (2006) Effects of exercise on breast cancer patients and survivors: a systemic review and meta-analysis. Can Med Assoc J 175:34–41CrossRef
13.
14.
Schmitz KH, Speck RM (2010) Risks and benefits of physical activity among breast cancer survivors who have completed treatment. Women’s Health 6:221–238PubMedCrossRef
15.
Carmichael AR, Daley AJ, Rea DW, Bowden SJ (2010) Physical activity and breast cancer outcome: a brief review of evidence, current practice and future direction. Eur J Surg Oncol 36:1139–1148PubMedCrossRef
16.
Barbaric M, Brooks E, Moore L, Cheifetz O (2010) Effects of physical activity on cancer survival: a systematic review. Physiother Can 62:25–34PubMedCrossRef
17.
Clough-Gorr KM, Ganz PA, Silliman RA (2010) Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up. Breast J 16:147–155PubMedCrossRef
18.
Servaes P, Verhagen C, Bleijenberg G (2002) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38:27–43PubMedCrossRef
19.
Gho S, Steele J, Munro B (2010) Is bra discomfort a barrier to exercise for breast cancer patients? Support Care Cancer 18:735–741PubMedCrossRef
20.
Whitney P, Budd D (1996) Think-aloud protocols and the study of comprehension. Discourse Process 21:341–351CrossRef
21.
22.
Warmuth MA, Bowen G, Prosnitz LR et al (1998) Complications of axillary lymph node dissection for carcinoma of the breast—a report based on a patient survey. Cancer 83:1362–1368PubMedCrossRef
23.
AIHW, Australia’s health. Australian Institute of Health and Welfare. Canberra: AIHW, 2010. Cat No. AUS 122
24.
AIHW, CA, and AACR, Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. Australian Institute of Health and Welfare, Cancer Australia & Australasian Association of Cancer Registries, 2008. Cancer Series no. 42: p. Cat. no. CAN 38
25.
ABS, Physical Activity in Australia: A Snapshot, 2007–08. 2011, Australian Bureau of Statistics
26.
Rabin EG, Heldt E, Hirakata VN, Fleck MP (2008) Quality of life predictors in breast cancer women. Eur J Oncol Nurs 12:53–57PubMedCrossRef
27.
Vance V, Mourtzakis M, McCargar L, Hanning R (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12:282–294PubMedCrossRef
28.
McInnes JA, Knobf MT (2001) Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer. Oncol Nurs Forum 28:675–684PubMed
29.
Su H et al (2010) Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors. Breast Cancer Res Tr 124(1):205–211CrossRef
30.
Mom CH, Buijs C, Willemse PHB, Mourits MJE, de Vries EGE (2006) Hot flushes in breast cancer patients. Crit Rev Oncol Hemat 57:63–77CrossRef
31.
Savard M, Savard J, Quesnel C, Ivers H (2009) The influence of breast cancer treatment on the occurrence of hot flashes. J Pain Symptom Manag 37:687–697CrossRef
32.
Rock CL et al (1999) Factors associated with weight gain in women after diagnosis of breast cancer. J Am Diet Assoc 99(10):1212–1218PubMedCrossRef
33.
McInnes JA, Knobf MT (2001) Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer. Oncol Nurs Forum 28(4):675–684PubMed
34.
Demark-Wahnefried W, Peterson BL, Winer EP et al (2001) Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19:2381–2389PubMed
35.
36.
Schmitz KH et al (2009) Weight lifting in women with breast-cancer-related lymphedema. New Engl J Med 361(7):664–673PubMedCrossRef
37.
Hayes SC, Johansson K, Stout NL et al (2012) Upper-body morbidity after breast cancer. Cancer 118:2237–2249PubMedCrossRef
38.
Jung BF et al (2003) Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain 104(1–2):1–13PubMedCrossRef
39.
40.
Hack TF et al (1999) Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17(1):143–149PubMed
41.
Chan DNS, Lui LYY, So WKW (2010) Effectiveness of exercise programmes on shoulder mobility and lymphoedema after axillary lymph node dissection for breast cancer: systematic review. J Adv Nurs 66(9):1902–1914PubMed
42.
Schmitz KH et al (2005) Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidem Biomar 14(7):1588–1595CrossRef
43.
Tolentino GP, Battaglini CL, Araújo SS et al (2010) Cardiorespiratory fitness and quality-of-life analysis posttreatment in breast cancer survivors. J Psychosoc Oncol 28:381–398PubMedCrossRef
Metadata
Title
Self-reported side effects of breast cancer treatment: a cross-sectional study of incidence, associations, and the influence of exercise
Authors
Sheridan A. Gho
Julie R. Steele
Sandra C. Jones
Bridget J. Munro
Publication date
01-03-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 3/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0142-4

Other articles of this Issue 3/2013

Cancer Causes & Control 3/2013 Go to the issue

Original paper

Racial disparities in advanced-stage colorectal cancer survival

Original Paper

The modifying effect of patient location on stage-specific survival following colorectal cancer using geosurvival models

Original paper

Risk factors for primary lung cancer among never smokers by gender in a matched case–control study

Original paper

Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women

Original paper

Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case–control study (the Bellvitge Colorectal Cancer Study)

Original Paper

Baseline E2 levels are higher in BRCA2 mutation carriers: a potential target for prevention?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits